132 related articles for article (PubMed ID: 19052182)
1. Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy.
Jardi R; Rodriguez-Frias F; Tabernero D; Homs M; Schaper M; Esteban R; Buti M
J Clin Microbiol; 2009 Feb; 47(2):485-8. PubMed ID: 19052182
[TBL] [Abstract][Full Text] [Related]
2. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
[TBL] [Abstract][Full Text] [Related]
3. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
Mese S; Arikan M; Cakiris A; Abaci N; Gumus E; Kursun O; Onel D; Ustek D; Kaymakoglu S; Badur S; Yenen OS; Bozkaya E
J Gen Virol; 2013 Dec; 94(Pt 12):2729-2738. PubMed ID: 24045109
[TBL] [Abstract][Full Text] [Related]
4. Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.
Basaras M; Arrese E; Blanco S; Arroyo LS; Ruiz P; Cisterna R
Intervirology; 2013; 56(3):190-4. PubMed ID: 23594698
[TBL] [Abstract][Full Text] [Related]
5. Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.
Niesters HG; Zoulim F; Pichoud C; Buti M; Shapiro F; D'Heuvaert N; Celis L; Doutreloigne J; Sablon E
Antimicrob Agents Chemother; 2010 Mar; 54(3):1283-9. PubMed ID: 20065049
[TBL] [Abstract][Full Text] [Related]
6. HBV/4DR 9G test and its comparison with INNO-LiPA HBV multi-DR test for the detection of drug-resistant Hepatitis B virus.
Chantratita W; Song KS; Pongthanapisith V; Thongbaiphet N; Angkanavin K; Nimse SB; Sonawane MD; Kim T
J Virol Methods; 2016 Nov; 237():58-63. PubMed ID: 27581951
[TBL] [Abstract][Full Text] [Related]
7. [Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].
Aydoğan S; Ergünay K; Balaban Y; Alp A; Simşek H; Tatar G; Hasçelik G; Us D
Mikrobiyol Bul; 2013 Jul; 47(3):472-81. PubMed ID: 23971924
[TBL] [Abstract][Full Text] [Related]
8. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
Lok AS; Zoulim F; Locarnini S; Mangia A; Niro G; Decraemer H; Maertens G; Hulstaert F; De Vreese K; Sablon E
J Clin Microbiol; 2002 Oct; 40(10):3729-34. PubMed ID: 12354872
[TBL] [Abstract][Full Text] [Related]
9. Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.
Jang H; Kim J; Choi JJ; Son Y; Park H
J Clin Microbiol; 2010 Sep; 48(9):3127-31. PubMed ID: 20573874
[TBL] [Abstract][Full Text] [Related]
10. Overestimation of incidence of hepatitis B virus mixed-genotype infections by use of the new line probe INNO-LiPA genotyping assay.
Mercier M; Laperche S; Girault A; Sureau C; Servant-Delmas A
J Clin Microbiol; 2011 Mar; 49(3):1154-6. PubMed ID: 21177906
[TBL] [Abstract][Full Text] [Related]
11. Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.
Libbrecht E; Doutreloigne J; Van De Velde H; Yuen MF; Lai CL; Shapiro F; Sablon E
J Clin Microbiol; 2007 Dec; 45(12):3935-41. PubMed ID: 17913933
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
Tadokoro K; Suzuki F; Kobayashi M; Yamaguchi T; Nagano M; Egashira T; Kumada H
J Virol Methods; 2011 Jan; 171(1):67-73. PubMed ID: 20950650
[TBL] [Abstract][Full Text] [Related]
13. Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions.
Aberle SW; Kletzmayr J; Watschinger B; Schmied B; Vetter N; Puchhammer-Stöckl E
J Clin Microbiol; 2001 May; 39(5):1972-4. PubMed ID: 11326026
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naïve patient.
Guo JJ; Li QL; Shi XF; Zhang DZ; Zeng AZ; Feng T; Huang AL
Antiviral Res; 2009 Feb; 81(2):180-3. PubMed ID: 18948142
[TBL] [Abstract][Full Text] [Related]
15. Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolates.
Fang J; Wichroski MJ; Levine SM; Baldick CJ; Mazzucco CE; Walsh AW; Kienzle BK; Rose RE; Pokornowski KA; Colonno RJ; Tenney DJ
Antimicrob Agents Chemother; 2009 Jul; 53(7):2762-72. PubMed ID: 19433559
[TBL] [Abstract][Full Text] [Related]
16. Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?
Lee GH; Aung MO; Dan YY; Lee YM; Mak B; Low HC; Lim K; Thwin MA; Tan PS; Lim SG
J Med Virol; 2013 Jan; 85(1):26-33. PubMed ID: 23023992
[TBL] [Abstract][Full Text] [Related]
17. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.
Hussain M; Fung S; Libbrecht E; Sablon E; Cursaro C; Andreone P; Lok AS
J Clin Microbiol; 2006 Mar; 44(3):1094-7. PubMed ID: 16517902
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype.
Osiowy C; Giles E
J Clin Microbiol; 2003 Dec; 41(12):5473-7. PubMed ID: 14662927
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance.
Choi YJ; Kim HS; Lee SH; Park JS; Nam HS; Kim HJ; Kim CJ; Jeong DJ; Park KS; Baek KA
Arch Virol; 2011 Sep; 156(9):1517-24. PubMed ID: 21594598
[TBL] [Abstract][Full Text] [Related]
20. Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.
Lupo J; Larrat S; Hilleret MN; Germi R; Boyer V; Nicod S; Barguès G; Leroy V; Seigneurin JM; Zarski JP; Morand P
J Virol Methods; 2009 Mar; 156(1-2):52-8. PubMed ID: 19041345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
